Middle East and Africa CAR-T Cell Therapy Treatment Market - Industry Trends and Forecast to 2028

Middle East and Africa CAR-T Cell Therapy Treatment Market - Industry Trends and Forecast to 2028

Middle East and Africa CAR-T cell therapy treatment market is projected to register a CAGR of 28.7% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 to 2028
Market Segmentation:
Middle East and Africa CAR-T Cell Therapy Treatment, By Product (Autologous CAR-T Cells, Allogeneic CAR-T Cells), Structure (First Generation CAR-T Cells, Second Generation Car-T Cells, Third Generation CAR-T Cells, Fourth Generation CAR-T Cells), Targeted Antigens (Antigens on Solid Tumors, Antigens on Hematologic Malignancies, Others), Brand (Yescarta, Kymriah, Tecartus, Others), Therapeutic Application (Hematological Malignancies, Pancreatic Cancer, Breast Cancer, Lung Cancer, Gastric Cancer, Multiple Myeloma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma, Acute Lymphoblastic Leukemia, Others), End User (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospitals Pharmacy, Others), Country (Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

Some of the major factors contributing to the growth of Middle East and Africa CAR-T cell therapy treatment market are:

• Rise in awareness about immunotherapies
• Presence of pipeline therapies

Market Players:
The key market players for Middle East and Africa CAR-T cell therapy treatment market are listed below:

• Amgen Inc.
• Johnson & Johnson Services, Inc
• AbbVie Inc.
• Novartis AG
• TC BIOPHARM

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Middle East And Africa Car-t Cell Therapy Treatment Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Product Lifeline Curve
2.8 Primary Interviews With Key Opinion Leaders
2.9 Dbmr Market Position Grid
2.10 Vendor Share Analysis
2.11 Market Product Coverage Grid
2.12 Secondary Sources
2.13 Assumptions
3 Executive Summary
4 Premium Insight
5 Epidemiology
6 Pipeline Analysis
7 Market Overview
7.1 Drivers
7.1.1 Increase In Usage Of Car-t Cell Therapy For The Treatment Of Cancer And Infectious Diseases
7.1.2 Increasing Prevalence Of Cancer
7.1.3 Rise In Awareness About Immunotherapies
7.1.4 Increasing Investment In Research And Development
7.1.5 Adoption Of Car-t Cell Therapy Treatment In Emerging Markets
7.2 Restraints
7.2.1 Adverse Side Effects Of Therapies
7.2.2 High Cost Associated With Therapies
7.2.3 Logistic Challenge Associated With Car-t Therapies
7.2.4 Availability Of Alternatives For Tumor Treatment
7.3 Opportunities
7.3.1 Presence Of Pipeline Products
7.3.2 Strategic Initiatives By Market Players
7.3.3 Rise In Expenditure In Healthcare Sector
7.4 Challenges
7.4.1 Long Approval Time For Immunotherapies
7.4.2 Lack Of Skilled Professionals
8 Impact Of Covid-19 On Middle East And Africa Car-t Cell Therapy Treatment Market
8.1 Impact On Price
8.2 Impact On Demand
8.3 Impact On Supply Chain
8.4 Strategic Decision For Manufacturers
8.5 Conclusion
9 Middle East And Africa Car-t Cell Therapy Treatment Market, By Product
9.1 Overview
9.2 Autologous Car-t Cells
9.3 Allogeneic Car-t Cells
10 Middle East And Africa Car-t Cell Therapy Treatment Market, By Structure
10.1 Overview
10.2 First Generation Car-t Cells
10.3 Second Generation Car-t Cells
10.4 Third Generation Car-t Cells
10.5 Fourth Generation Car-t Cells
11 Middle East And Africa Car-t Cell Therapy Treatmentmarket, By Targeted Antigens
11.1 Overview
11.2 Antigens On Hematologic Malignancies
11.2.1 Cluster Of Differentiation-19 (Cd-19)
11.2.2 Cluster Of Differentiation-30 (Cd-30)
11.2.3 Cluster Of Differentiation-22 (Cd-22)
11.2.4 Cluster Of Differentiation-20 (Cd-20)
11.2.5 Cluster Of Differentiation-33 (Cd-33)
11.3 Antigens On Solid Tumors
11.3.1 Human Epidermal Growth Factor Receptor-2 (Her-2)
11.3.2 Epidermal Growth Factor Receptors Variant Iii (Egfrv-iii)
11.3.3 Mesothelin (Msln)
11.3.4 Prostate-specific Membrane Antigen (Psma)
11.3.5 Interleukin-13ra2 (Il13ra2)
11.3.6 Disialoganglioside 2 (Gd2)
11.3.7 Glypican-3 (Gpc3)
11.3.8 Others
11.4 Others
12 Middle East And Africa Car-t Cell Therapy Treatment Market, By Brand
12.1 Overview
12.2 Yescarta
12.3 Kymriah
12.4 Tecartus
12.5 Others
13 Middle East And Africa Car-t Cell Therapy Treatment Market, By Therapeutic Application
13.1 Overview
13.2 Follicular Lymphoma
13.3 Diffuse Large B-cell Lymphoma
13.4 Acute Lymphoblastic Leukaemia (All)
13.5 Mantle Cell Lymphoma
13.6 Multiple Myeloma
13.7 Hematologic Malignancies
13.7.1 Leukemia
13.7.2 Lymphoma
13.7.3 Myeloma
13.7.4 Others
13.8 Lung Cancer
13.9 Chronic Lymphocytic Leukemia
13.10 Gastric Cancer
13.11 Pancreatic Cancer
13.12 Breast Cancer
13.13 Others
14 Middle East And Africa Car-t Cell Therapy Treatment Market, By End User
14.1 Overview
14.2 Hospitals
14.3 Specialty Clinics
14.4 Others
15 Middle East And Africa Car-t Cell Therapy Treatment Market, By Distribution Channel
15.1 Overview
15.2 Hospital Pharmacy
15.3 Others
16 Middle East And Africa Car-t Cell Therapy Treatment Market By Geography
16.1 Middle East And Africa
16.1.1 Saudi Arabia
16.1.2 Uae
16.1.3 South Africa
16.1.4 Israel
16.1.5 Kuwait
16.1.6 Egypt
16.1.7 Rest Of Middle East And Africa
17 Middle East And Africa Car-t Cell Therapy Treatment Market: Company Landscape
17.1 Company Share Analysis: Middle East And Africa
18 Swot Analysis
19 Company Profile
19.1 Kite Pharma (A Subsidiary Of Gilead Sciences, Inc.)
19.1.1 Company Snapshot
19.1.2 Revenue Analysis
19.1.3 Company Share Analysis
19.1.4 Product Portfolio
19.1.5 Recent Developments
19.2 Novartis Ag
19.2.1 Company Snapshot
19.2.2 Revenue Analysis
19.2.3 Company Share Analysis
19.2.4 Product Portfolio
19.2.5 Recent Developments
19.3 Abbvie Inc.
19.3.1 Company Snapshot
19.3.2 Revenue Analysis
19.3.3 Product Portfolio
19.3.4 Recent Developments
19.4 Adaptimmune Therapeutics Plc
19.4.1 Company Snapshot
19.4.2 Revenue Analysis
19.4.3 Product Portfolio
19.4.4 Recent Developments
19.5 Amgen Inc.
19.5.1 Company Snapshot
19.5.2 Revenue Analysis
19.5.3 Pipeline Product Portfolio
19.5.4 Recent Developments
19.6 Atara Biotherapeutics, Inc.
19.6.1 Company Snapshot
19.6.2 Pipeline Product Portfolio
19.6.3 Recent Developments
19.7 Aurora Biopharma
19.7.1 Company Snapshot
19.7.2 Pipeline Product Portfolio
19.7.3 Recent Developments
19.8 Autolus
19.8.1 Company Snapshot
19.8.2 Product Portfolio
19.8.3 Recent Developments
19.9 Bellicum Phamaceuticals, Inc.
19.9.1 Company Snapshot
19.9.2 Revenue Analysis
19.9.3 Product Portfolio
19.9.4 Recent Developments
19.10 Bioatla Inc.
19.10.1 Company Snapshot
19.10.2 Product Portfolio
19.10.3 Recent Developments
19.11 Bluebird Bio, Inc.
19.11.1 Company Snapshot
19.11.2 Revenue Analysis
19.11.3 Product Portfolio
19.11.4 Recent Developments
19.12 Bristol-myers Squibb Company
19.12.1 Company Snapshot
19.12.2 Revenue Analysis
19.12.3 Product Portfolio
19.12.4 Recent Developments
19.13 Carina Biotech
19.13.1 Company Snapshot
19.13.2 Product Portfolio
19.13.3 Recent Developments
19.14 Cartherics Pty Ltd
19.14.1 Company Snapshot
19.14.2 Product Portfolio
19.14.3 Recent Developments
19.15 Cartesian Therapeutics, Inc.
19.15.1 Company Snapshot
19.15.2 Pipeline Product Portfolio
19.15.3 Recent Developments
19.16 Cellectis Sa
19.16.1 Company Snapshot
19.16.2 Revenue Analysis
19.16.3 Product Portfolio
19.16.4 Recent Developments
19.17 Celyad Oncology Sa
19.17.1 Company Snapshot
19.17.2 Pipeline Product Portfolio
19.17.3 Recent Developments
19.18 Johnson & Johnson Services, Inc.
19.18.1 Company Snapshot
19.18.2 Revenue Analysis
19.18.3 Product Portfolio
19.18.4 Recent Developments
19.19 Sorrento Therapeutics, Inc.
19.19.1 Company Snapshot
19.19.2 Pipeline Product Portfolio
19.19.3 Recent Developments
19.20 Tc Biopharm Limited
19.20.1 Company Snapshot
19.20.2 Pipeline Product Portfolio
19.20.3 Recent Developments
19.21 Tessa Therapeutics Ltd.
19.21.1 Company Snapshot
19.21.2 Pipeline Product Portfolio
19.21.3 Recent Developments
19.22 Tmunity Therapeutics
19.22.1 Company Snapshot
19.22.2 Pipeline Product Portfolio
19.22.3 Recent Developments
19.23 Mustang Bio
19.23.1 Company Snapshot
19.23.2 Pipeline Product Portfolio
19.23.3 Recent Developments
19.24 Xyphos (A Subsidiary Of Astellas Pharma Inc.)
19.24.1 Company Snapshot
19.24.2 Revenue Analysis
19.24.3 Pipeline Product Portfolio
19.24.4 Recent Developments
19.25 Ziopharm Oncology, Inc.
19.25.1 Company Snapshot
19.25.2 Product Portfolio
19.25.3 Recent Developments
20 Questionnaire
21 Related Reports
List Of Tables
Table 1 Middle East And Africa Car-t Cell Therapy Treatment Market, Pipeline Analysis
Table 2 Below Provided Are The Alternative Chemotherapies Of Car-t Cell Therapy:
Table 3 Total Health Spending By The U.S. (2015-2016)
Table 4 Middle East And Africa Car-t Cell Therapy Treatmentmarket, By Molecule, 2019-2028 (Usd Million)
Table 5 Middle East And Africa Autologous Car-t Cells In Car-t Cell Therapy Treatmentmarket, By Region, 2017-2028 (Usd Million)
Table 6 Middle East And Africa Allogeneic Car-t Cells In Car-t Cell Therapy Treatmentmarket, By Region, 2019-2028 (Usd Million)
Table 7 Middle East And Africa Car-t Cell Therapy Treatmentmarket, By Structure, 2019-2028 (Usd Million)
Celyad Is Engaged In The Manufacturing Of Cyad-211, A First Generation Car-t Cell Therapy Expressing Bcma Targeting Chimeric Antigen Receptor Which Interferes With The Expression Of The Cd3ζ Of T Cell Receptor Complex.
Table 8 Middle East And Africa First Generation Car-t Cells In Car-t Cell Therapy Treatment Market, By Region, 2019-2028 (Usd Million)
Table 9 Middle East And Africa Second Generation Car-t Cells In Car-t Cell Therapy Treatment Market, By Region, 2019-2028 (Usd Million)
Table 10 Middle East And Africa Third Generation Car-t Cells In Car-t Cell Therapy Treatment Market, By Region, 2019-2028 (Usd Million)
Table 11 Middle East And Africa Third Generation Car-t Cells In Car-t Cell Therapy Treatment Market, By Region, 2019-2028 (Usd Million)
Table 12 Middle East And Africa Car-t Cell Therapy Treatmentmarket, By Targeted Antigens, 2019-2028 (Usd Million)
Table 13 Middle East And Africa Antigens On Hematologic Malignancies In Car-t Cell Therapy Treatment Market, By Region, 2019-2028 (Usd Million)
Table 14 Middle East And Africa Antigens On Hematologic Malignancies In Car-t Cell Therapy Treatment Market, By Antigens On Hematologic Malignancies, 2019-2028 (Usd Million)
Table 15 Middle East And Africa Antigens On Solid Tumors In Car-t Cell Therapy Treatmentmarket, By Region, 2017-2028 (Usd Million)
Table 16 Middle East And Africa Antigens On Solid Tumors In Car-t Cell Therapy Treatment Market, By Antigens On Solid Tumors, 2019-2028 (Usd Million)
Table 17 Middle East And Africa Others In Car-t Cell Therapy Treatmentmarket, By Region, 2017-2028 (Usd Million)
Table 18 Middle East And Africa Yescarta In Car-t Cell Therapy Treatment Market, By Region, 2017-2028 (Usd Million)
Table 19 Middle East And Africa Yescarta In Car-t Cell Therapy Treatment Market, By Region, 2017-2028 (Usd Million)
Table 20 Middle East And Africa Kymriah In Car-t Cell Therapy Treatment Market, By Region, 2017-2028 (Usd Million)
Table 21 Middle East And Africa Tecartus In Car-t Cell Therapy Treatment Market, By Region, 2017-2028 (Usd Million)
Table 22 Middle East And Africa Others In Car-t Cell Therapy Treatment Market, By Region, 2017-2028 (Usd Million)
Table 23 Middle East And Africa Car-t Cell Therapy Treatment Market, By Therapeutic Type, 2019-2028 (Usd Million)
Table 24 Middle East And Africa Follicular Lymphoma In Car-t Cell Therapy Treatment Market, By Therapeutic Type, 2017-2028 (Usd Million)
Table 25 Middle East And Africa Diffuse Large B-cell Lymphoma In Car-t Cell Therapy Treatment Market, By Region, 2017-2028 (Usd Million)
Table 26 Middle East And Africa Acute Lymphoblastic Leukaemia (All) In Car-t Cell Therapy Treatment Market, By Region, 2017-2028 (Usd Million)
Table 27 Middle East And Africa Mantle Cell Lymphoma In Car-t Cell Therapy Treatment Market, By Region, 2017-2028 (Usd Million)
Table 28 Middle East And Africa Multiple Myeloma In Car-t Cell Therapy Treatment Market, By Region, 2017-2028 (Usd Million)
Table 29 Middle East And Africa Hematologic Malignancies In Car-t Cell Therapy Treatment Market, By Region, 2017-2028 (Usd Million)
Table 30 Middle East And Africa Hematologic Malignancies On Solid Tumors In Car-t Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (Usd Million)
Table 31 Middle East And Africa Lung Cancer In Car-t Cell Therapy Treatment Market, By Region, 2017-2028 (Usd Million)
Table 32 Middle East And Africa Chronic Lymphocytic Leukemia In Car-t Cell Therapy Treatment Market, By Region, 2017-2028 (Usd Million)
Table 33 Middle East And Africa Gastric Cancer In Car-t Cell Therapy Treatment Market, By Region, 2017-2028 (Usd Million)
Table 34 Middle East And Africa Pancreatic Cancer In Car-t Cell Therapy Treatment Market, By Region, 2017-2028 (Usd Million)
Table 35 Middle East And Africa Breast Cancer In Car-t Cell Therapy Treatment Market, By Region, 2017-2028 (Usd Million)
Table 36 Middle East And Africa Others In Car-t Cell Therapy Treatment Market, By Region, 2017-2028 (Usd Million)
Table 37 Middle East And Africa Car-t Cell Therapy Treatment Market, By End User, 2019-2028 (Usd Million)
Table 38 Middle East And Africa Hospitals In Car-t Cell Therapy Treatment Market, By Therapeutic Type, 2017-2028 (Usd Million)
Table 39 Middle East And Africa Specialty Clinics In Car-t Cell Therapy Treatment Market, By Region, 2017-2028 (Usd Million)
Table 40 Middle East And Africa Others In Car-t Cell Therapy Treatment Market, By Region, 2017-2028 (Usd Million)
Table 41 Middle East And Africa Car-t Cell Therapy Treatment Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 42 Middle East And Africa Hospital Pharmacy In Car-t Cell Therapy Treatment Market, By Distribution Channel, 2017-2028 (Usd Million)
Table 43 Middle East And Africa Others In Car-t Cell Therapy Treatment Market, By Region, 2017-2028 (Usd Million)
Table 44 Middle East And Africa Car-t Cell Therapy Treatment Market, By Region, 2019-2028 (Usd Million)
Table 45 Middle East And Africa Car-t Cell Therapy Treatment Market, By Product, 2019-2028 (Usd Million)
Table 46 Middle East And Africa Car-t Cell Therapy Treatment Market, By Structure 2019-2028 (Usd Million)
Table 47 Middle East And Africa Car-t Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (Usd Million)
Table 48 Middle East And Africa Antigens On Hematologic Malignancies In Car-t Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (Usd Million)
Table 49 Middle East And Africa Antigens On Solid Tumors In Car-t Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (Usd Million)
Table 50 Middle East And Africa Car-t Cell Therapy Treatment Market, By Brand, 2019-2028 (Usd Million)
Table 51 Middle East And Africa Car-t Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (Usd Million)
Table 52 Middle East And Africa Hematologic Malignancies In Car-t Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (Usd Million)
Table 53 Middle East And Africa Car-t Cell Therapy Treatment Market, By End User, 2019-2028 (Usd Million)
Table 54 Middle East And Africa Car-t Cell Therapy Treatment Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 55 Saudi Arabia Car-t Cell Therapy Treatment Market, By Product, 2019-2028 (Usd Million)
Table 56 Saudi Arabia Car-t Cell Therapy Treatment Market, By Structure 2019-2028 (Usd Million)
Table 57 Saudi Arabia Car-t Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (Usd Million)
Table 58 Saudi Arabia Antigens On Hematologic Malignancies In Car-t Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (Usd Million)
Table 59 Saudi Arabia Antigens On Solid Tumors In Car-t Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (Usd Million)
Table 60 Saudi Arabia Car-t Cell Therapy Treatment Market, By Brand, 2019-2028 (Usd Million)
Table 61 Saudi Arabia Car-t Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (Usd Million)
Table 62 Saudi Arabia Hematologic Malignancies In Car-t Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (Usd Million)
Table 63 Saudi Arabia Car-t Cell Therapy Treatment Market, By End User, 2019-2028 (Usd Million)
Table 64 Saudi Arabia Car-t Cell Therapy Treatment Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 65 Uae Car-t Cell Therapy Treatment Market, By Product, 2019-2028 (Usd Million)
Table 66 Uae Car-t Cell Therapy Treatment Market, By Structure 2019-2028 (Usd Million)
Table 67 Uae Car-t Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (Usd Million)
Table 68 Uae Antigens On Hematologic Malignancies In Car-t Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (Usd Million)
Table 69 Uae Antigens On Solid Tumors In Car-t Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (Usd Million)
Table 70 Uae Car-t Cell Therapy Treatment Market, By Brand, 2019-2028 (Usd Million)
Table 71 Uae Car-t Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (Usd Million)
Table 72 Uae Hematologic Malignancies In Car-t Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (Usd Million)
Table 73 Uae Car-t Cell Therapy Treatment Market, By End User, 2019-2028 (Usd Million)
Table 74 Uae Car-t Cell Therapy Treatment Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 75 South Africa Car-t Cell Therapy Treatment Market, By Product, 2019-2028 (Usd Million)
Table 76 South Africa Car-t Cell Therapy Treatment Market, By Structure 2019-2028 (Usd Million)
Table 77 South Africa Car-t Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (Usd Million)
Table 78 South Africa Antigens On Hematologic Malignancies In Car-t Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (Usd Million)
Table 79 South Africa Antigens On Solid Tumors In Car-t Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (Usd Million)
Table 80 South Africa Car-t Cell Therapy Treatment Market, By Brand, 2019-2028 (Usd Million)
Table 81 South Africa Car-t Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (Usd Million)
Table 82 South Africa Hematologic Malignancies In Car-t Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (Usd Million)
Table 83 South Africa Car-t Cell Therapy Treatment Market, By End User, 2019-2028 (Usd Million)
Table 84 South Africa Car-t Cell Therapy Treatment Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 85 Israel Car-t Cell Therapy Treatment Market, By Product, 2019-2028 (Usd Million)
Table 86 Israel Car-t Cell Therapy Treatment Market, By Structure 2019-2028 (Usd Million)
Table 87 Israel Car-t Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (Usd Million)
Table 88 Israel Antigens On Hematologic Malignancies In Car-t Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (Usd Million)
Table 89 Israel Antigens On Solid Tumors In Car-t Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (Usd Million)
Table 90 Israel Car-t Cell Therapy Treatment Market, By Brand, 2019-2028 (Usd Million)
Table 91 Israel Car-t Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (Usd Million)
Table 92 Israel Hematologic Malignancies In Car-t Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (Usd Million)
Table 93 Israel Car-t Cell Therapy Treatment Market, By End User, 2019-2028 (Usd Million)
Table 94 Israel Car-t Cell Therapy Treatment Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 95 Kuwait Car-t Cell Therapy Treatment Market, By Product, 2019-2028 (Usd Million)
Table 96 Kuwait Car-t Cell Therapy Treatment Market, By Structure 2019-2028 (Usd Million)
Table 97 Kuwait Car-t Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (Usd Million)
Table 98 Kuwait Antigens On Hematologic Malignancies In Car-t Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (Usd Million)
Table 99 Kuwait Antigens On Solid Tumors In Car-t Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (Usd Million)
Table 100 Kuwait Car-t Cell Therapy Treatment Market, By Brand, 2019-2028 (Usd Million)
Table 101 Kuwait Car-t Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (Usd Million)
Table 102 Kuwait Hematologic Malignancies In Car-t Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (Usd Million)
Table 103 Kuwait Car-t Cell Therapy Treatment Market, By End User, 2019-2028 (Usd Million)
Table 104 Kuwait Car-t Cell Therapy Treatment Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 105 Egypt Car-t Cell Therapy Treatment Market, By Product, 2019-2028 (Usd Million)
Table 106 Egypt Car-t Cell Therapy Treatment Market, By Structure 2019-2028 (Usd Million)
Table 107 Egypt Car-t Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (Usd Million)
Table 108 Egypt Antigens On Hematologic Malignancies In Car-t Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (Usd Million)
Table 109 Egypt Antigens On Solid Tumors In Car-t Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (Usd Million)
Table 110 Egypt Car-t Cell Therapy Treatment Market, By Brand, 2019-2028 (Usd Million)
Table 111 Egypt Car-t Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (Usd Million)
Table 112 Egypt Hematologic Malignancies In Car-t Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (Usd Million)
Table 113 Egypt Car-t Cell Therapy Treatment Market, By End User, 2019-2028 (Usd Million)
Table 114 Egypt Car-t Cell Therapy Treatment Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 115 Egypt Car-t Cell Therapy Treatment Market, By Product, 2019-2028 (Usd Million)
List Of Figures
Figure 1 Middle East And Africa Car-t Cell Therapy Treatment Market: Segmentation
Figure 2 Middle East And Africa Car-t Cell Therapy Treatment Market: Data Triangulation
Figure 3 Middle East And Africa Car-t Cell Therapy Treatment Market: Droc Analysis
Figure 4 Middle East And Africa Car-t Cell Therapy Treatment Market: Middle East And Africa Vs Regional Market Analysis
Figure 5 Middle East And Africa Car-t Cell Therapy Treatment Market: Company Research Analysis
Figure 6 Middle East And Africa Car-t Cell Therapy Treatment Market: Multivariate Modelling
Figure 7 Middle East And Africa Car-t Cell Therapy Treatment Market: Interview Demographics
Figure 8 Middle East And Africa Car-t Cell Therapy Treatment Market: Dbmr Market Position Grid
Figure 9 Middle East And Africa Car-t Cell Therapy Treatment Market: Vendor Share Analysis
Figure 10 Middle East And Africa Car-t Cell Therapy Treatment Market: Market Product Coverage Grid
Figure 11 Middle East And Africa Car-t Cell Therapy Treatment Market: Segmentation
Figure 12 Increasing Investment In Research And Development Is Expected To Drive The Middle East And Africa Car-t Cell Therapy Treatment Market In The Forecast Period Of 2021 To
Figure 13 Autologus Car-t Cells Segment Is Expected To Account For The Largest Share Of The Middle East And Africa Car-t Cell Therapy Treatment Market In 2021 &
Figure 14 Drivers, Restraints, Opportunities And Challenges Of Middle East And Africa Car-t Cell Therapy Treatment Market
Figure 15 New Cancer Cases Worldwide, (2018)
Figure 16 Middle East And Africa Cancer Incidence (2018)
Figure 17 Cancer Death By Type (In Million), World,
Figure 18 Middle East And Africa Car-t Cell Therapy Treatmentmarket: By Product,
Figure 19 Middle East And Africa Car-t Cell Therapy Treatmentmarket: By Product, 2019-2028 (Usd Million)
Figure 20 Middle East And Africa Car-t Cell Therapy Treatmentmarket: By Product, Cagr (2021-2028)
Figure 21 Middle East And Africa Car-t Cell Therapy Treatmentmarket: By Product, Lifeline Curve
Figure 22 Middle East And Africa Car-t Cell Therapy Treatmentmarket: By Structure,
Figure 23 Middle East And Africa Car-t Cell Therapy Treatmentmarket: By Structure, 2019-2028 (Usd Million)
Figure 24 Middle East And Africa Car-t Cell Therapy Treatmentmarket: By Structure, Cagr (2021-2028)
Figure 25 Middle East And Africa Car-t Cell Therapy Treatmentmarket: By Structure, Lifeline Curve
Figure 26 Middle East And Africa Car-t Cell Therapy Treatmentmarket: By Targeted Antigens,
Figure 27 Middle East And Africa Car-t Cell Therapy Treatmentmarket: By Targeted Antigens, 2019-2028 (Usd Million)
Figure 28 Middle East And Africa Car-t Cell Therapy Treatmentmarket: By Targeted Antigens, Cagr (2021-2028)
Figure 29 Middle East And Africa Car-t Cell Therapy Treatmentmarket: By Targeted Antigens, Lifeline Curve
Figure 30 Middle East And Africa Car-t Cell Therapy Treatment Market: By Brand,
Figure 31 Middle East And Africa Car-t Cell Therapy Treatment Market: By Brand, 2020-2028 (Usd Million)
Figure 32 Middle East And Africa Car-t Cell Therapy Treatment Market: By Brand, Cagr (2020-2028)
Figure 33 Middle East And Africa Car-t Cell Therapy Treatment Market: By Brand, Lifeline Curve
Figure 34 Middle East And Africa Car-t Cell Therapy Treatment Market: By Therapeutic Application,
Figure 35 Middle East And Africa Car-t Cell Therapy Treatment Market: By Therapeutic Application, 2020-2028 (Usd Million)
Figure 36 Middle East And Africa Car-t Cell Therapy Treatment Market: By Therapeutic Application, Cagr (2020-2028)
Figure 37 Middle East And Africa Car-t Cell Therapy Treatment Market: By Therapeutic Application, Lifeline Curve
Figure 38 Middle East And Africa Car-t Cell Therapy Treatment Market: By End User,
Figure 39 Middle East And Africa Car-t Cell Therapy Treatment Market: By End User, 2020-2028 (Usd Million)
Figure 40 Middle East And Africa Car-t Cell Therapy Treatment Market: By End User, Cagr (2020-2028)
Figure 41 Middle East And Africa Car-t Cell Therapy Treatment Market: By End User, Lifeline Curve
Figure 42 Middle East And Africa Car-t Cell Therapy Treatment Market: By Distribution Channel,
Figure 43 Middle East And Africa Car-t Cell Therapy Treatment Market: By Distribution Channel, 2020-2028 (Usd Million)
Figure 44 Middle East And Africa Car-t Cell Therapy Treatment Market: By Distribution Channel, Cagr (2020-2028)
Figure 45 Middle East And Africa Car-t Cell Therapy Treatment Market: By Distribution Channel, Lifeline Curve
Figure 46 Middle East And Africa Car-t Cell Therapy Treatment Market: Snapshot (2020)
Figure 47 Middle East And Africa Car-t Cell Therapy Treatment Market: By Country (2020)
Figure 48 Middle East And Africa Car-t Cell Therapy Treatment Market: By Country (2021 & 2028)
Figure 49 Middle East And Africa Car-t Cell Therapy Treatment Market: By Country (2020 & 2028)
Figure 50 Middle East And Africa Car-t Cell Therapy Treatment Market: By Product (2021-2028)
Figure 51 Middle East And Africa Car-t Cell Therapy Treatment Market: Company Share 2020 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings